12 research outputs found
Time domain reflectometry (TDR) potential for soil condition monitoring of geotechnical assets
The performance of geotechnical assets is influenced by various external factors including time and changing loading and environmental conditions. These changes could reduce the asset’s ability to maintain its function, potentially resulting in failure, which could be extremely disruptive and expensive to remediate; thus, the ability to monitor the long-term condition of the ground is clearly desirable as this could function as an early-warning system, permitting intervention prior to failure. This study demonstrates, for the first time, the potential of using time domain reflectometry (TDR) for long-term monitoring of the relative health of an asset (via water content and dry density) in a field trial where a clayey sandy silt was exposed to leaking water from a pipe. TDR sensors were able to provide detailed information on the variation in the soil conditions and detect abrupt changes that would relay a prompt for asset inspections or interventions. It is proposed that TDR could be used alone or together with other shallow geophysical techniques for long-term condition monitoring of critical geotechnical assets. Early-warning systems could be based on thresholds defined from the values or the relative change of the measured parameter
A Targeted Search for Point Sources of EeV Photons with the Pierre Auger Observatory
Simultaneous measurements of air showers with the fluorescence and surface detectors of the Pierre Auger Observatory allow a sensitive search for EeV photon point sources. Several Galactic and extragalactic candidate objects are grouped in classes to reduce the statistical penalty of many trials from that of a blind search and are analyzed for a significant excess above the background expectation. The presented search does not find any evidence for photon emission at candidate sources, and combined p-values for every class are reported. Particle and energy flux upper limits are given for selected candidate sources. These limits significantly constrain predictions of EeV proton emission models from non-transient Galactic and nearby extragalactic sources, as illustrated for the particular case of the Galactic center region
Search for patterns by combining cosmic-ray energy and arrival directions at the Pierre Auger Observatory
Energy-dependent patterns in the arrival directions of cosmic rays are searched for using data of the Pierre Auger Observatory. We investigate local regions around the highest-energy cosmic rays with E > = 6×1019 eV by analyzing cosmic rays with energies above E > = 5×1018 eV arriving within an angular separation of approximately 15°. We characterize the energy distributions inside these regions by two independent methods, one searching for angular dependence of energy-energy correlations and one searching for collimation of energy along the local system of principal axes of the energy distribution. No significant patterns are found with this analysis. The comparison of these measurements with astrophysical scenarios can therefore be used to obtain constraints on related model parameters such as strength of cosmic-ray deflection and density of point sources
Gibbs–non-Gibbs properties for evolving Ising models on trees
In this paper we study homogeneous Gibbs measures on a Cayley tree, subjected to an infinite-temperature Glauber evolution, and consider their (non-)Gibbsian properties. We show that the intermediate Gibbs state (which in zero field is the free-boundary-condition Gibbs state) behaves differently from the plus and the minus state. E.g. at large times, all configurations are bad for the intermediate state, whereas the plus configuration never is bad for the plus state. Moreover, we show that for each state there are two transitions. For the intermediate state there is a transition from a Gibbsian regime to a non-Gibbsian regime where some, but not all configurations are bad, and a second one to a regime where all configurations are bad.
For the plus and minus state, the two transitions are from a Gibbsian regime to a non-Gibbsian one and then back to a Gibbsian regime again.
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Liver diseases have become a major health threat across
Europe, and the face of European hepatology is changing
due to the cure of viral hepatitis C and the control of
chronic viral hepatitis B, the increasingly widespread
unhealthy use of alcohol, the epidemic of obesity, and
undiagnosed or untreated liver disease in migrant
populations. Consequently, Europe is facing a looming
syndemic, in which socioeconomic and health inequities
combine to adversely affect liver disease prevalence,
outcomes, and opportunities to receive care. In addition,
the COVID-19 pandemic has magnified pre-existing
challenges to uniform implementation of policies and
equity of access to care in Europe, arising from national
borders and the cultural and historical heterogeneity of
European societies. In following up on work from
the Lancet Commission on liver disease in the UK and
epidemiological studies led by the European Association
for the Study of the Liver (EASL), our multidisciplinary
Commission, comprising a wide range of public health,
medical, and nursing specialty groups, along with
patient representatives, set out to provide a snapshot of
the European landscape on liver diseases and to propose
a framework for the principal actions required to
improve liver health in Europe. We believe that a joint
European process of thinking, and construction of
uniform policies and action, implementation, and
evaluation can serve as a powerful mechanism to
improve liver care in Europe and set the way for similar
changes globally.
On the basis of these data, we present ten actionable
recommendations, half of which are oriented towards
health-care providers and half of which focus primarily
on health policy. A fundamental shift must occur, in
which health promotion, prevention, proactive casefinding, early identification of progressive liver fibrosis,
and early treatment of liver diseases replace the current
emphasis on the management of end-stage liver disease
complications. A considerable focus should be put on
underserved and marginalised communities, including
early diagnosis and management in children, and we
provide proposals on how to better target disadvantaged
communities through health promotion, prevention, and
care using multilevel interventions acting on current
barriers.
Underlying this transformative shift is the need to
enhance awareness of the preventable and treatable
nature of many liver diseases. Therapeutic nihilism,
which is prevalent in current clinical practice across a
range of medical specialities as well as in many patients
themselves, has to end. We wish to challenge medical
specialty protectionism and invite a broad range of
stakeholders, including primary care physicians, nurses,
patients, peers, and members of relevant communities,
along with medical specialists trained in obesity, diabetes,
liver disease, oncology, cardiovascular disease, public
health, addictions, infectious diseases, and more, to
engage in integrated person-centred liver patient care
across classical medical specialty boundaries. This shift
includes a revision in how we converse about liver
disease and speak with our patients, and a reappraisal of
disease-related medical nomenclature conducted to
increase awareness and reduce the social stigmatisation
associated with liver disease.
Reimbursement mechanisms and insurance systems
must be harmonised to account for patient-centric,
multimorbidity models of care across a range of medical
specialties, and the World Health Assembly resolution
to improve the transparency and fairness of market
prices for medicines throughout Europe should be
reinforced. Finally, we outline how Europe can move
forward with implementation of effective policy action
on taxation, food reformulation, and product labelling,
advertising, and availability, similar to that implemented
for tobacco, to reduce consumption of alcohol, ultraprocessed foods, and foods with added sugar, especially
among young people. We should utilise the window of
opportunity created by the COVID-19 pandemic to
overcome fragmentation and the variability of health
prevention policies and research across Europe. We
argue that the liver is a window to the 21st-century
health of the European population. Through our
proposed syndemic approach to liver disease and social
and health inequities in Europe, the liver will serve as a
sentinel for improving the overall health of European
populations
Anisotropy studies around the galactic centre at EeV energies with the Auger Observatory
Data from the Pierre Auger Observatory are analyzed to search for anisotropies near the direction of the Galactic Centre at EeV energies. The exposure of the surface array in this part of the sky is already significantly larger than that of the fore-runner experiments. Our results do not support previous findings of localized excesses in the AGASA and SUGAR data. We set an upper bound on a point-like flux of cosmic rays arriving from the Galactic Centre which excludes several scenarios predicting sources of EeV neutrons from Sagittarius A. Also the events detected simultaneously by the surface and fluorescence detectors (the 'hybrid' data set), which have better pointing accuracy but are less numerous than those of the surface array alone, do not show any significant localized excess from this direction. © 2006 Elsevier B.V. All rights reserved
Study of the processes χcJ → Ξ−Ξ¯+ and Ξ0Ξ¯0
Using 448.1 × 106 ψ(3686) decays collected with the BESIII detector at the BEPCII e+e− storage rings, the branching fractions and angular distributions of the decays χcJ → Ξ−Ξ¯¯¯¯+ and Ξ0Ξ¯¯¯¯0 (J = 0, 1, 2) are measured based on a partial-reconstruction technique. The decays χc1 → Ξ0Ξ¯¯¯¯0 and χc2 → Ξ0Ξ¯¯¯¯0 are observed for the first time with statistical significances of 7σ and 15σ, respectively. The results of this analysis are in good agreement with previous measurements and have significantly improved precision
Measurement of electrons from semileptonic heavy-flavour hadron decays at midrapidity in pp and Pb–Pb collisions at √sNN = 5.02 TeV
The differential invariant yield as a function of transverse momentum (pT) of electrons from semileptonic heavy-flavour hadron decays was measured at midrapidity in central (0–10%), semi-central (30–50%) and peripheral (60–80%) lead–lead (Pb–Pb) collisions at √sNN = 5.02 TeV in the pT intervals 0.5–26 GeV/c (0–10% and 30–50%) and 0.5–10 GeV/c (60–80%). The production cross section in proton–proton (pp) collisions at √s = 5.02 TeV was measured as well in 0.5 < pT < 10 GeV/c and it lies close to the upper band of perturbative QCD calculation uncertainties up to pT = 5 GeV/c and close to the mean value for larger pT. The modification of the electron yield with respect to what is expected for an incoherent superposition of nucleon–nucleon collisions is evaluated by measuring the nuclear modification factor RAA. The measurement of the RAA in different centrality classes allows in-medium energy loss of charm and beauty quarks to be investigated. The RAA shows a suppression with respect to unity at intermediate pT, which increases while moving towards more central collisions. Moreover, the measured RAA is sensitive to the modification of the parton distribution functions (PDF) in nuclei, like nuclear shadowing, which causes a suppression of the heavy-quark production at low pT in heavy-ion collisions at LHC
Global burden of 87 risk factors in 204 countries and territories, 1990–2019 : a systematic analysis for the Global Burden of Disease Study 2019
Background: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods: GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk–outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk–outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk–outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden. Findings: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10·8 million (95% uncertainty interval [UI] 9·51–12·1) deaths (19·2% [16·9–21·3] of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8·71 million (8·12–9·31) deaths (15·4% [14·6–16·2] of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253–350) DALYs (11·6% [10·3–13·1] of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0–9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10–24 years, alcohol use for those aged 25–49 years, and high systolic blood pressure for those aged 50–74 years and 75 years and older. Interpretation: Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. Funding: Bill & Melinda Gates Foundation.Peer reviewe
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Background: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods: GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk–outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk–outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk–outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden. Findings: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10·8 million (95% uncertainty interval [UI] 9·51–12·1) deaths (19·2% [16·9–21·3] of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8·71 million (8·12–9·31) deaths (15·4% [14·6–16·2] of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253–350) DALYs (11·6% [10·3–13·1] of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0–9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10–24 years, alcohol use for those aged 25–49 years, and high systolic blood pressure for those aged 50–74 years and 75 years and older. Interpretation: Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. Funding: Bill & Melinda Gates Foundation